Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 6573215, 7 pages
http://dx.doi.org/10.1155/2016/6573215
Research Article

Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait

1Clinical Services Department, Dasman Diabetes Institute, P.O. Box 1180, 15462 Kuwait, Kuwait
2Biochemistry & Molecular Biology Unit, Dasman Diabetes Institute, P.O. Box 1180, 15462 Kuwait, Kuwait

Received 9 July 2015; Revised 1 November 2015; Accepted 4 November 2015

Academic Editor: Giovanni Annuzzi

Copyright © 2016 May Sewify et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Kunin, “Chemoprophylaxis and suppressive therapy in the management of urinary tract infections,” Journal of Antimicrobial Chemotherapy, vol. 33, supplement A, pp. 51–62, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Gupta, D. F. Sahm, D. Mayfield, and W. E. Stamm, “Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis,” Clinical Infectious Diseases, vol. 33, no. 1, pp. 89–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. V. de Lastours and B. Foxman, “Urinary tract infection in diabetes: epidemiologic considerations,” Current Infectious Disease Reports, vol. 16, no. 1, article 389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Patterson and V. T. Andriole, “Bacterial urinary tract infections in diabetes,” Infectious Disease Clinics of North America, vol. 11, no. 3, pp. 735–750, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Saleem and B. Daniel, “Prevalence of urinary tract infection among patients with diabetes in Bangalore city,” International Journal of Emerging Sciences, vol. 1, no. 2, pp. 133–142, 2011. View at Google Scholar
  6. A. Ward, P. Alvarez, L. Vo, and S. Martin, “Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012),” Journal of Medical Economics, vol. 17, no. 3, pp. 176–183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Bonadio, S. Costarelli, G. Morelli, and T. Tartaglia, “The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection,” BMC Infectious Diseases, vol. 6, article 54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Geerlings, R. P. Stolk, M. J. L. Camps, P. M. Netten, T. J. Collet, and A. I. M. Hoepelman, “Risk factors for symptomatic urinary tract infection in women with diabetes,” Diabetes Care, vol. 23, no. 12, pp. 1737–1741, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. S. E. Geerlings, R. P. Stolk, M. J. L. Camps et al., “Asymptomatic bacteriuria may be considered a complication in women with diabetes,” Diabetes Care, vol. 23, no. 6, pp. 744–749, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. E. J. Boyko, S. D. Fihn, D. Scholes, C.-L. Chen, E. H. Normand, and P. Yarbro, “Diabetes and the risk of acute urinary tract infection among postmenopausal women,” Diabetes Care, vol. 25, no. 10, pp. 1778–1783, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Szucs, I. Cserhati, G. Csapo, and V. Balazs, “The relation between diabetes mellitus and infections of the unirary tract. A clinical, qualitative and quantitative bacteriological study based upon 300 diabetics and 200 controls,” The American Journal of the Medical Sciences, vol. 240, pp. 186–191, 1960. View at Google Scholar
  12. K. M. Johnsson, A. Ptaszynska, B. Schmitz, J. Sugg, S. J. Parikh, and J. F. List, “Urinary tract infections in patients with diabetes treated with dapagliflozin,” Journal of Diabetes and its Complications, vol. 27, no. 5, pp. 473–478, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. E. Geerlings, E. C. Brouwer, K. P. M. van Kessel, W. Gaastra, and A. M. Hoepelman, “Cytokine secretion is impaired in women with diabetes mellitus,” in Genes and Proteins Underlying Microbial Urinary Tract Virulence, vol. 485 of Advances in Experimental Medicine and Biology, pp. 255–262, Springer, 2000. View at Publisher · View at Google Scholar
  14. A. Ronald, “The etiology of urinary tract infection: traditional and emerging pathogens,” American Journal of Medicine, vol. 113, supplement 1, pp. 14S–19S, 2002. View at Google Scholar · View at Scopus
  15. M. Aswani Srinivas, U. K. Chandrashekar, K. N. Shivashankara, and B. C. Pruthvi, “Clinical profile of urinary tract infections in diabetics and non-diabetics,” Australasian Medical Journal, vol. 7, no. 1, pp. 29–34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–496, 1966. View at Google Scholar · View at Scopus
  17. L. M. A. J. Muller, K. J. Gorter, E. Hak et al., “Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus,” Clinical Infectious Diseases, vol. 41, no. 3, pp. 281–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Benfield, J. S. Jensen, and B. G. Nordestgaard, “Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome,” Diabetologia, vol. 50, no. 3, pp. 549–554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Al Benwan, N. Al Sweih, and V. O. Rotimi, “Etiology and antibiotic susceptibility patterns of community- and hospital-acquired urinary tract infections in a general hospital in Kuwait,” Medical Principles and Practice, vol. 19, no. 6, pp. 440–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Gorter, E. Hak, N. P. A. Zuithoff, A. I. M. Hoepelman, and G. E. H. M. Rutten, “Risk of recurrent acute lower urinary tract infections and prescription pattern of antibiotics in women with and without diabetes in primary care,” Family Practice, vol. 27, no. 4, pp. 379–385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. E. Nicolle, “Urinary tract infections in special populations. diabetes, renal transplant, HIV infection, and spinal cord injury,” Infectious Disease Clinics of North America, vol. 28, no. 1, pp. 91–104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. Geerlings, “Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment,” International Journal of Antimicrobial Agents, vol. 31, supplement 1, pp. 54–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Sauerwein, “Urinary tract infection in patients with neurogenic bladder dysfunction,” International Journal of Antimicrobial Agents, vol. 19, no. 6, pp. 592–597, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. L. E. Nicolle, G. Capuano, A. Fung, and K. Usiskin, “Urinary tract infection in randomized phase III studies of canagliflozin, a sodium glucose co-transporter 2 inhibitor,” Postgraduate Medicine, vol. 126, no. 1, pp. 7–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Johnsson, A. Ptaszynska, B. Schmitz, J. Sugg, S. J. Parikh, and J. F. List, “Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin,” Journal of Diabetes and Its Complications, vol. 27, no. 5, pp. 479–484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. R. James and A. Hijaz, “Lower urinary tract symptoms in women with diabetes mellitus: a current review,” Current Urology Reports, vol. 15, no. 10, article 440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Al Rashdan and Y. Al Nesef, “Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey,” Angiology, vol. 61, no. 1, pp. 42–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Simkhada, “Urinary tract infection and antibiotic sensitivity pattern among diabetics,” Nepal Medical College Journal, vol. 15, no. 1, pp. 1–4, 2013. View at Google Scholar · View at Scopus
  29. N. Al Sweih, W. Jamal, and V. O. Rotimi, “Spectrum and antibiotic resistance of uropathogens isolated from hospital and community patients with urinary tract infections in two large hospitals in Kuwait,” Medical Principles and Practice, vol. 14, no. 6, pp. 401–407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. H. MacVane, L. O. Tuttle, and D. P. Nicolau, “Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection,” Journal of Hospital Medicine, vol. 9, no. 4, pp. 232–238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. S. Sandhu, A. Sehgal, O. Gupta, and A. Singh, “Aminoglycoside nephrotoxicity revisited,” Journal, Indian Academy of Clinical Medicine, vol. 8, no. 4, pp. 331–333, 2007. View at Google Scholar · View at Scopus